Intellia Therapeutics Inc (NTLA) is higher by Monday morning, with the stock gaining 4.05% in pre-market trading to 29.26. NTLA's short-term technical score of 7 indicates that the stock has traded less bullishly over the last month than 93% of stocks on the market. In the Biotechnology industry, which ranks 120 out of 146 industries, the stock ranks higher than 15% of stocks. Intellia Therapeutics Inc has risen 5.56% over the past month, closing at $26.32 on October 23. During this period of time, the stock fell as low as $23.16 and as high as $29.75. NTLA has an average analyst recommendation of Strong Buy. The company has an average price target of $78.45.
NTLA has an Overall Score of 36. Find out what this means to you and get the rest of the rankings on NTLA!